---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-000051"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2025-01-06T23:59:59+00:00"
generated_at: "2026-05-28T10:28:28.515265+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology agrees to be acquired by Renovaro for $3.00/share in preferred stock

## Summary
- POAI shareholders to receive 1 share of Renovaro preferred stock per POAI share, redeemable for $3.00 after 18 months.
- Preferred stock convertible to Renovaro common at 1:1 after RENB trades at $4.50+ for 30 consecutive days.
- Renovaro to purchase up to 2.33M POAI shares at $1.07 if warrants unexercised by Jan 15, 2025.
- Merger conditioned on Renovaro raising $15M and POAI shareholder approval; definitive docs by Feb 28, 2025.
- Combined company expects >30% near-term operating expense reduction via AI/ML platform synergies.

## SEC filing metadata
- accession: 0001171843-25-000051
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2025-01-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184325000051/0001171843-25-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184325000051/f8k_010625.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-000051
- JSON: https://secwatch.observer/filing/0001171843-25-000051.json
- Plain text: https://secwatch.observer/filing/0001171843-25-000051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.